Clinical Trials Directory

Trials / Completed

CompletedNCT06000683

Empowering Patients' Lung Cancer Screening Uptake

Empowering Patients' Lung Cancer Screening Uptake (Empower LCS)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
79 (actual)
Sponsor
University of California, Irvine · Academic / Other
Sex
All
Age
50 Years – 80 Years
Healthy volunteers
Accepted

Summary

Lung cancer is the leading cause of cancer related mortality. Lung cancer screening (LCS) with low dose computed tomography (LDCT) decreases mortality rate of lung cancer by 20%. Yet many patients who are eligible for lung cancer screening are still falling through the cracks which prevents patients the ability to detect lung cancer early. This study will test the effect of a a multi-level intervention on ordering LDCT within 6 months after patient enrollment. Our proposed intervention includes (1) Primary care provider notifications of patients' LCS eligibility; (2) patients' education ; (3) patients' referral to financial navigation resources; and (4) patients' reminder to discuss LCS during PCP visit.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPatient educationPatients will be sent information (in preferred language) on lung cancer risk, lung cancer screening (LCS) benefits, harms, false positive rates, recommendations of follow-up for positive results, and exam insurance coverage.
BEHAVIORALReferral to financial navigation resourcesPatients who self-report needing help with health-related social risks at baseline will be sent a brochure (in preferred language) from patient advocate foundation (PAF), a national non-profit financial navigation organization, where patients can self-refer.
BEHAVIORALPatient RemindersWithin 2 weeks prior to primary care appointment, patients will receive a text message or a phone call (if not having a phone that receives text messaging) encouraging patients to discuss the LCS with their provider.
BEHAVIORALProvider ReminersWithin 2 weeks prior to primary care appointment, providers will be notified of their patient's eligibility for LCS.

Timeline

Start date
2023-10-13
Primary completion
2025-03-21
Completion
2025-11-25
First posted
2023-08-21
Last updated
2026-02-20
Results posted
2026-02-03

Locations

7 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT06000683. Inclusion in this directory is not an endorsement.